Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Rheumatology and Therapy|October 18, 2016
Assessing Methotrexate Adherence in Rheumatoid Arthritis: A Cross-Sectional SurveyDana B DiBenedetti, Xiaolei Zhou, Maria Reynolds, et al.Rheumatology and Therapy|October 18, 2016
Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another BiologicStephen S Johnston, Donna McMorrow, Amanda M Farr, et al.Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Cost-effectiveness of large-panel next-generation sequencing in guiding first-line treatment decisions for patients with nonsquamous advanced non-small cell lung cancerIbrahim M Abbass, Daniel M Sheinson, Anuj Shah, et al.Pharmacoeconomics - Open|December 18, 2025
Budget Impact of the LungFlag™ Predictive Risk Model for Lung Cancer ScreeningCarolina Heuser, Michael K Gould, Eran Choman, et al.Rheumatology and Therapy|October 18, 2016
Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid ArthritisMartin J Bergman, Eric P Elkin, Sarika Ogale, et al.JCO Oncology Practice|May 27, 2021
Association Between Medicare's National Coverage Determination and Utilization of Next-Generation SequencingDaniel M Sheinson, William B Wong, Carlos Flores, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2022
Associations Between Medicaid Insurance, Biomarker Testing, and Outcomes in Patients With Advanced NSCLCCary P Gross, Craig S Meyer, Sarika Ogale, et al.Journal of Managed Care & Specialty Pharmacy|December 16, 2021
Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non-small cell lung cancerApar Kishor Ganti, Chia-Wei Lin, Erru Yang, et al.Rheumatology (Oxford, England)|July 4, 2012
Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE studyVibeke Strand, Gerd R Burmester, Sarika Ogale, et al.The Journal of Rheumatology|January 17, 2014
Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatmentEdward C Keystone, Andrew Anisfeld, Sarika Ogale, et al.Pageof 5